Our goals
In 2010 Arthritis Research UK identified 10 key goals which we will be aiming to achieve over the next 10 years. We will assess progress against each of these goals using existing information sources and, where necessary, by collecting appropriate new data.
The goals will be reviewed annually. Arthritis Research UK cannot achieve these goals alone and we will actively encourage others in government, the NHS, academic institutions, industry and the third sector to work with us.
Our Partners
Arthritis Research UK will work with a range of partners to reduce the impact of arthritis, including:
- Government(s), nationally and internationally
- Other medical and medical research charities, nationally and internationally
- The health sciences industry
- The general public
- The NHS,
- Professional bodies, academic community and university sector.
At least half of the UK’s population will be aware of the pain and disability associated with arthritis and will know how to reduce their risk of developing it. Awareness and understanding of arthritis will increase.
Find out more
Treatments that accurately target arthritis will be identified for patients with most forms of arthritis, reducing pain, increasing mobility and allowing a normal quality of life.
Find out more
At least half of arthritis sufferers across all age groups will be able to undertake their normal everyday activities without pain.
Find out more
The number of working days lost and the number of claims for long term Disability Living Allowance as a direct result of arthritis will be halved.
Find out more
We will have a detailed understanding of the causes and consequences of most forms of arthritis.Reduce the number of deaths and severe complications from arthritis in all its forms The risk of life threatening complications of severe arthritis will be substantially reduced as a consequence of earlier and more effective treatment with the risk of premature death falling by 40 per cent.
Find out more
The risk of life threatening complications of severe arthritis will be substantially reduced as a consequence of earlier and more effective treatment with the risk of premature death falling by 40 per cent.
Find out more
Advances in knowledge will enable the development of new approaches to preserving joint function and minimising pain resulting from arthritis and therefore postpone the need for joint replacement. Such replacements will also last longer and the current rate of complications will be cut by 50 per cent.
Find out more
Development of more effective treatments will substantially lessen the impact of arthritis starting in childhood allowing at least 80 per cent of children affected to have a normal future life.
Find out more
There will be a well developed programme of research in the UK with the necessary expertise, investment and infrastructure to carry out internationally competitive research aimed at using the body’s own cells to replace worn out joints in disorders such as osteoarthritis
Find out more
Enough expert scientists and healthcare professionals together with the necessary investment and infrastructure will be in place to continue the fight against arthritis for the foreseeable future.
Find out more